These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12457428)

  • 21. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
    Orlowski JP; Wateska L
    Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
    Campo K; De Staebel O; Gijsbrechts E; van Waterschoot W
    Health Mark Q; 2005; 22(4):73-107. PubMed ID: 16597584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The marketing of estrogens for menopausal and postmenopausal women.
    Palmlund I
    J Psychosom Obstet Gynaecol; 1997 Jun; 18(2):158-64. PubMed ID: 9219112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pills that ate your profits.
    Meyer H
    Hosp Health Netw; 1998 Feb; 72(3):18-22. PubMed ID: 9483145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 28. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 29. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.
    Majumdar SR; Almasi EA; Stafford RS
    JAMA; 2004 Oct; 292(16):1983-8. PubMed ID: 15507584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
    Oldani MJ
    Med Anthropol Q; 2004 Sep; 18(3):325-56. PubMed ID: 15484967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical promotion and GP prescription behaviour.
    Windmeijer F; de Laat E; Douven R; Mot E
    Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pricing of prescription drugs and its impact on physicians' choice behavior.
    Miao-Sheng C; Yu-Ti S
    Health Care Manag Sci; 2008 Sep; 11(3):288-95. PubMed ID: 18826006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advertising and prescription drugs: promotion, education, and the public's health.
    Avorn J
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-104-8. PubMed ID: 14527239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ethics and economics of pharmaceutical pricing.
    Parker-Lue S; Santoro M; Koski G
    Annu Rev Pharmacol Toxicol; 2015; 55():191-206. PubMed ID: 25149920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The increasing necessity for market-based pharmaceutical prices.
    Calfee JE
    Pharmacoeconomics; 2000; 18 Suppl 1():47-57. PubMed ID: 11151309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct-to-consumer advertising is more profitable if it is misleading.
    Mansfield PR; Mintzes B
    N Z Med J; 2003 Sep; 116(1182):U610. PubMed ID: 14581959
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A; Davis C; Mulinari S
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Commercial effectiveness of the pharmaceutical industry. Industry cost-effectiveness and customers value].
    Mur Martí J; Vilardell Molas M
    Med Clin (Barc); 2004 May; 122(19):753-7. PubMed ID: 15171911
    [No Abstract]   [Full Text] [Related]  

  • 39. The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late?
    Kerwin R
    J Psychopharmacol; 2007 Mar; 21(2):131-3. PubMed ID: 17329287
    [No Abstract]   [Full Text] [Related]  

  • 40. Internet marketing of neuroproducts: new practices and healthcare policy challenges.
    Racine E; van der Loos HZ; Illes J
    Camb Q Healthc Ethics; 2007; 16(2):181-94. PubMed ID: 17539470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.